Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out ...

Danish pharma group Novo Nordisk has ... a connected inhaler device called Inspair that tracks and records breath actuations, an NFC-enabled add-on for prefilled syringes called Injay, and Datapen ...

SAE Media Group's 15th Annual Pre-Filled Syringes and Injectable ... Corporate Programme Vice President, Devices and Delivery Solutions, Novo Nordisk Steve Hoare, Quality, Regulatory Science ...

In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...

Thirty-seven-year-old Nupur Lalvani, who has been living with Type 1 diabetes since the age of eight, was dependent on ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Along with it, other form of insulin including human insulin from Novo Nordisk will continue to be available in vials & devices for patients across ... which are marketed primarily in the format of ...

Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand.

Two prefilled, disposable insulin pen devices were used: InnoLet and FlexPen (Novo Nordisk). Because the hospital ... Patients randomized to the vial and syringe group continued this method ...

The global market for prefilled syringes is expanding, driven by the rising prevalence of chronic illnesses, greater use of biologics and biosimilars, and a growing trend toward self-injection.

In a move which could shake up the diabetes market, Novo Nordisk is ... delivery from pen devices is preferred by a huge majority of diabetics over vials injected with syringes, due to its ...